Arrest-defective-1 protein (ARD1): Tumor suppressor or oncoprotein?

Hsu Ping Kuo, Mien Chie Hung

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Arrest-defect-1 protein (ARD1), an acetyltransferase, catalyzes N-α-acetylation in yeast. In mammalian cells, both N-α-acetylation and ε-acetylation induced by ARD1 have been reported. Emerging evidence has revealed that ARD1 is involved in a variety of cellular functions, including proliferation, apoptosis, autophagy, and differentiation and that dysregulation of ARD1 is associated with tumorigenesis and neurodegenerative disorder. This review will discuss recent discoveries regarding variations among the different ARD1 isoforms, the associated biological functions of ARD1, and ARD1 localization in different cells. We will also discuss the potential upstream regulators and downstream targets of ARD1 to provide new avenues for resolving its controversial roles in cancer development.

Original languageEnglish (US)
Pages (from-to)56-64
Number of pages9
JournalAmerican Journal of Translational Research
Volume2
Issue number1
StatePublished - 2010

Keywords

  • ARD1
  • Acetylation
  • Acetyltransferase
  • Tumorigenesis

ASJC Scopus subject areas

  • Molecular Medicine
  • Clinical Biochemistry
  • Cancer Research

Fingerprint

Dive into the research topics of 'Arrest-defective-1 protein (ARD1): Tumor suppressor or oncoprotein?'. Together they form a unique fingerprint.

Cite this